198 related articles for article (PubMed ID: 26813962)
21. Red cell alloimmunization in RhD positive pregnant women and neonatal outcome.
Sankaralingam P; Jain A; Bagga R; Kumar P; Marwaha N
Transfus Apher Sci; 2016 Aug; 55(1):153-8. PubMed ID: 27324408
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, Specificity and Titration of Red Cell Alloantibodies in Multiparous Antenatal Females at a Tertiary Care Centre from North India.
Sidhu M; Bala R; Akhtar N; Sawhney V
Indian J Hematol Blood Transfus; 2016 Sep; 32(3):307-11. PubMed ID: 27429523
[TBL] [Abstract][Full Text] [Related]
23. [Incidence of erythrocyte alloimmunization in pregnant women in olomouc region].
Holusková I; Lubušký M; Studničková M; Procházka M
Ceska Gynekol; 2013 Jan; 78(1):56-61. PubMed ID: 23607383
[TBL] [Abstract][Full Text] [Related]
24. Red cell alloimmunization among antenatal women attending tertiary care center in Jamnagar, Gujarat, India.
Dholakiya SK; Bharadva S; Vachhani JH; Upadhyay BS
Asian J Transfus Sci; 2021; 15(1):52-56. PubMed ID: 34349457
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Rhesus C and D Alloantibodies among Rhesus-Negative Women of Child Bearing Age at a Tertiary Hospital in South-West Nigeria.
Otomewo L; John-Olabode S; Okunade K; Olorunfemi G; Ajie I
Niger J Clin Pract; 2020 Dec; 23(12):1759-1766. PubMed ID: 33355832
[TBL] [Abstract][Full Text] [Related]
26. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
27. Management of Wrong Blood Transfusion to an RhD Negative Woman in Labor.
Titze TL; Hamnvik LHD; Hauglum IM; Carlsen AET; Tjeldhorn L; Nguyen NT; Akkök ÇA
Int J Womens Health; 2023; 15():1-6. PubMed ID: 36628052
[TBL] [Abstract][Full Text] [Related]
28. Misclassification of RhD variants among pregnant women: a systematic review.
Owaidah AY; Yamani LZ
J Med Life; 2023 Jul; 16(7):981-989. PubMed ID: 37900088
[TBL] [Abstract][Full Text] [Related]
29. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
Moise KJ
Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
[TBL] [Abstract][Full Text] [Related]
30. Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn.
Dziegiel MH; Krog GR; Hansen AT; Olsen M; Lausen B; Nørgaard LN; Bergholt T; Rieneck K; Clausen FB
Transfus Med Hemother; 2021 Oct; 48(5):306-315. PubMed ID: 34803574
[TBL] [Abstract][Full Text] [Related]
31. A case report on non-D HDFN: Highlighting the role of antibody screening in RhD positive antenatal women.
Singh B; Chaudhary R; Elhence P; Bharati JK; Srivastava A
Asian J Transfus Sci; 2022; 16(1):121-123. PubMed ID: 36199394
[TBL] [Abstract][Full Text] [Related]
32. Reassessing critical maternal antibody threshold in RhD alloimmunization: a 16-year retrospective cohort study.
Walsh CA; Doyle B; Quigley J; McAuliffe FM; Fitzgerald J; Mahony R; Higgins S; Carroll S; McParland P
Ultrasound Obstet Gynecol; 2014 Dec; 44(6):669-73. PubMed ID: 24706487
[TBL] [Abstract][Full Text] [Related]
33. [Standardization of the quantitative flow cytometric test with anti-D antibodies for fetomaternal hemorrhage in RhD negative women].
Spychalska J; Uhrynowska M; Pyl H; Klimczak-Jajor E; Kopeć I; Peciakowska M; Gutowska R; Gawlak M; Słomska S; Dąbkowska S; Szczecina R; Dębska M; Brojer E
Ginekol Pol; 2015 Jul; 86(7):486-93. PubMed ID: 26376524
[TBL] [Abstract][Full Text] [Related]
34. Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis.
Clausen FB; Rieneck K; Krog GR; Bundgaard BS; Dziegiel MH
Methods Mol Biol; 2019; 1885():347-359. PubMed ID: 30506209
[TBL] [Abstract][Full Text] [Related]
35. Distribution of antenatal alloimmunization in the southern districts of West Bengal and its significant associated factor.
Naik A; Bhattacharya P; Das P; Mukherjee K; Mukhopadhyay P
Asian J Transfus Sci; 2020; 14(2):119-125. PubMed ID: 33767537
[TBL] [Abstract][Full Text] [Related]
36. Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia.
Kureba AA; Gudu W; Mersha A; Jemal E; Abdosh AA
Int J Womens Health; 2023; 15():571-578. PubMed ID: 37077284
[TBL] [Abstract][Full Text] [Related]
37. Anti-D alloimmunisation in pregnant women with DEL phenotype in China.
Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ
Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335
[TBL] [Abstract][Full Text] [Related]
38. Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma.
Yazer MH; Panko G; Holcomb JB; Kaplan A; Leeper C; Seheult JN; Triulzi DJ; Spinella PC
Hematology; 2023 Dec; 28(1):2161215. PubMed ID: 36607150
[TBL] [Abstract][Full Text] [Related]
39. Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
Seheult JN; Callum J; Delaney M; Drake R; Dunbar NM; Harm SK; Hess JR; Jackson BP; Javanbakht A; Moore SA; Murphy MF; Raval JS; Staves J; Tuott EE; Wendel S; Ziman A; Yazer MH;
Transfusion; 2022 Aug; 62 Suppl 1():S185-S192. PubMed ID: 35748692
[TBL] [Abstract][Full Text] [Related]
40. Prevention of RhD alloimmunization in RhD negative women.
Lubusky M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Mar; 154(1):3-7. PubMed ID: 20445704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
